Agenus, Inc. (AGEN)
2.925
-0.28
(-8.59%)
USD |
NASDAQ |
Mar 05, 16:00
2.925
0.00 (0.00%)
After-Hours: 20:00
Agenus Cash from Investing (Quarterly) : 0.076M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cardiff Oncology, Inc. | 10.75M |
| Curis, Inc. | 0.00 |
| LadRx Corp. | 0.00 |
| Plus Therapeutics, Inc. | 1.297M |
| Windtree Therapeutics, Inc. | -0.789M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.74M |
| Cash from Financing (Quarterly) | 6.683M |
| Free Cash Flow | -89.31M |
| Free Cash Flow Per Share (Quarterly) | -0.4485 |
| Free Cash Flow to Equity (Quarterly) | 47.08M |
| Free Cash Flow to Firm (Quarterly) | -1.493M |
| Free Cash Flow Yield | -113.1% |